To monitor the therapy response quantitatively, we measured residual disease in the spleen with a sensitive qPCR copy number assay for the Eμ‐Myc transgene of moribund lymphoma mice and non‐transgenic littermates as positive and negative controls, respectively (Fig 7F). The gene discussed is MYC; the disease is lymphoma.